The inhibition of Hh pathway by vismodegib can treat the upregulation of autophagy in CML cells; hence, the combination of vismodegib with silencing of ATG5 and ATG7 can cause significant increase in CML cell death [205]. Here, ATG5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.